chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had a dizzy reaction to the Pfizer Covid 19 Vaccine; Has had a very bad time.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (Unknown). The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "Had a dizzy reaction to the Pfizer Covid 19 Vaccine"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "Has had a very bad time.".  Additional information: Two years ago caller received three doses of the Pfizer Covid-19 Vaccine. Had a dizzy reaction to the Pfizer Covid 19 Vaccine. Ever since, has had a very bad time.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300018909 same reporter/patient/AE, different dose;US-PFIZER INC-202300018910 same reporter/patient/AE, different dose;
Pt recvd 1st dose of vax 13AUG92 & on the following day, devel acute bronchitis characterized by a chilly sensation, non-productive cough, t100.8 & malaise; pt also noted lymphadenopathy;
My last menstrual period was Nov 2019. I started having spots yesterday, Monday, May 10. Today, May 11,  I am having my period again.
RECEIVED A DOSE OF VACCINE DRAWN FROM A VIAL THAT WAS HELD IN THE FRIDGE FOR NEARLY 24 HOURS; This spontaneous report received from a patient concerned a 22 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, and expiry: 07-AUG-2021) dose was not reported, administered on 29-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-JUL-2021, the subject experienced received a dose of vaccine drawn from a vial that was held in the fridge for nearly 24 hours. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of received a dose of vaccine drawn from a vial that was held in the fridge for nearly 24 hours was not reported. This report was non-serious.
I've been sicker than a dog.  Extreme shaking due to being so cold due to high fever.  Nausea.  Hurt all over.
Injection site itching; Injection site redness; Big red mark around the injection site; Swollen; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Big red mark around the injection site), INJECTION SITE SWELLING (Swollen), INJECTION SITE ERYTHEMA (Injection site redness) and VACCINATION SITE PRURITUS (Injection site itching) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 300042460) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Big red mark around the injection site) and INJECTION SITE SWELLING (Swollen). On 14-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Injection site redness). On 15-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site itching). On 09-Jan-2021, INJECTION SITE ERYTHEMA (Big red mark around the injection site) and INJECTION SITE SWELLING (Swollen) had resolved. At the time of the report, INJECTION SITE ERYTHEMA (Injection site redness) and VACCINATION SITE PRURITUS (Injection site itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications not reported by the reporter. Treatment details not reported by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Case number PHEH2016US023506, is an initial spontaneous report from a consumer received on 12 Sep 2016. This report refers to a 77 years old of unknown gender patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with one single dose of expired FLUVIRIN (batch number:157104) at a dose of 0.5 ml, intramuscularly on 12 Sep 2016. It was stated that, 2015/2016 expired vaccine was administered to 05 patients on 12 Sep 2016. No adverse event was reported following this medication error (expired product administered). The case was assessed as non-serious by the consumer.
Induration, swelling, fever, erythema and cellulitis in right upper arm. DEPO MEDROL 40 mg IM, DECADRON 8 mg IM. ROCEPHIN 1 gm IM. BACTRIM 800/160 mg BID x 10d PO. Cephalexin 500 mg BID x 10d. 3/14/17. Improved but not resolved in 1 week.
Headache, Myalgia, NauseaVomiting, 2/1 Nausous, severe stomach pain 1/20 potential COVID exposure Narrative:
I got the vaccine in my right arm. About 30 min after the vaccine, I started feeling numbness/tingling in my right jaw/mandible area that spread behind my ear. Over about an hour or 2 I could feel the numbness/tingling/strange sensation move across the top of my right lip and into my right nostril.  I took benadryl and it seemed to stop the spreading but the strange sensation stayed on the right side of my face for about 4 days afterwards.
R arm with severe redness/swelling & induration.  Worsened over several days pt treated with ABX for possible cellulitis & steroids/BENADRYL for allergic rxn.
back has hurt every day since receiving the vaccine; entire body hurt; extremely fatigued, "it felt like someone get me with a Mack truck"; was smoldering hot; heart rate was raising; DIARRHEA; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (DIARRHEA), FEELING HOT (was smoldering hot), HEART RATE INCREASED (heart rate was raising), BACK PAIN (back has hurt every day since receiving the vaccine) and MYALGIA (entire body hurt) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event .  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), VITAMIN D NOS and CALCIUM for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced DIARRHOEA (DIARRHEA). On 21-Jan-2021, the patient experienced FEELING HOT (was smoldering hot) and HEART RATE INCREASED (heart rate was raising). On an unknown date, the patient experienced BACK PAIN (back has hurt every day since receiving the vaccine), MYALGIA (entire body hurt) and FATIGUE (extremely fatigued, "it felt like someone get me with a Mack truck"). At the time of the report, DIARRHOEA (DIARRHEA), FEELING HOT (was smoldering hot), HEART RATE INCREASED (heart rate was raising), BACK PAIN (back has hurt every day since receiving the vaccine), MYALGIA (entire body hurt) and FATIGUE (extremely fatigued, "it felt like someone get me with a Mack truck") was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included Statin ( Cholesterol ), 3 Heart Medication. No treatment information provided   Reporter did not allow further contact
My back swelled up and was covered with hives and welts.  I couldn't lift anything.  Several episodes of severe chest pain, I thought it might be a heart attack at first.  Exhaustion and not feeling well for about 4 weeks after the shot.  Still having diarreha, not sure if it's from the shot or my IBS but I wasn't having it prior to my 2nd dose.
Temp 101.6, chills, extreme body aches and HA, nausea, vomiting, hyperactive bowel movements, (7 soft formed in 9 hours) resolved about 30 hours from onset.
Information has ben received from a physician concerning a 29 year old female with no past medical history and no known drug allergies who on 11/19/2001 was vaccinated with the first dose of varicela SC. There was no illness at the time of vaccination. Concomitant therapy included Zoloft. It was reported that on 12/01/2001, the pt developed a varicella like rash at the injection site with approximately 20 vesicular lesions. The physician reported that the rash "looks like atypical chicken pox." It was reported that the pt recovered on 12/10/2001. No further info is expected.
Swollen lymph node above left collarbone; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 10:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 27Apr2021, the patient experienced swollen lymph node above left collarbone. The event swollen lymph node above left collarbone did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph node above left collarbone was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a physician concerning a 30 week old male patient who on an unspecified date when he was 10 weeks old was vaccinated with the first dose of ROTATEQ orally.  On an unspecified date, the patient received the third dose of ROTARIX.  When the patient was 26 weeks old, he received the second dose of ROTATEQ orally.  Subsequently, 32 days after the last vaccination, when he was 30 weeks old, the patient experienced intussusception.  At the time of the report the patient's outcome was unknown.  Upon internal review intussusception was considered to be an other important medical event.  This is an amended report.  The narrative was updated.  The patient received the third dose of ROTARIX (vaccines dose and series was unspecified).  No further information is available.
Sore, tender rash at injection site,  chills, sweats, body aches, insomnia, major fatigue  After 28 hours took ibuprofen and felt much better
1 min. after injection Tdap into right deltoid patients muscle developed a lump size of a nickel. Advise patient to take TYLENOL or BENADRYL after arriving home today. Patient stated she felt sorness/tenderness but other than that she was ok to drive herself home.
This spontaneous report was received from a licensed nurse practitioner refers to an unspecified number of patients of unknown age and gender. The nurse reported that unspecified number of improperly stored via (Oka/Merck) VARIVAX 0.5 milliliter (ml) doses have been administered subcutaneously to unspecified number of patients on unspecified dates. The vaccine have been stored at -10 C (celsius) (above recommended temperature range in product information) since July 2013. No adverse effect reported. Follow up information has been received from a healthcare worker concerning a patient of unspecified age and gender. On 30-JUL-2013, the patient was vaccinated with a dose (Oka/Merck) VARIVAX (lot # H018786, exp date: 15-OCT-2014) that had been stored at -10 C (celcius) (above recommended temperature range in product information) since July 2013. No adverse effects reported. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Symptoms for 3 months since the vaccine: Chronic Exhaustion Dizziness Erratic Blood Pressure - Extremely high to extremely low - hospitalized twice Erratic Heart Reate Chest Pain
p/vax pt devel a rash;the following day pt was examined w/following noted: chickenpox which was very small in size, w/6 to 8 across the back of the neck, 8 on the arms & legs, 8 on back &  abd & 6 in scalp;impression was insect bites ;
Right and Left legs had cellulitis, redness. Did require IV antibiotics for 4 days.  5/22/09 Received hospital medical records of 4/29-4/30/2009. FINAL DX: cellulitis left thigh Records reveal patient experienced progressive erythema w/streaking, induration, &  pain at injection site and fever, x 3 days.  Tx w/IV antibiotics & admitted overnight for observation.  Improved & d/c to home next day on continued oral antibiotics.
I also feel joint soreness most of the time; experienced a low-grade fever of 99.2 to 100.4; I wake up with sweet-drenched clothing each morning; This case was reported by a consumer and described the occurrence of fever in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th March 2020, the patient received the 1st dose of Shingrix. On 31st March 2020, 1 days after receiving Shingrix, the patient experienced sweating. On 1st April 2020, the patient experienced fever. On an unknown date, the patient experienced joint pain. On an unknown date, the outcome of the fever, joint pain and sweating were not recovered/not resolved.   It was unknown if the reporter considered the fever, joint pain and sweating to be related to Shingrix.  Additional details were provided as follows: The age at the vaccination was not reported. The patient received Shingrix shots on Monday (the day before reporting). The patient had experienced a low-grade fever of 99.2 to 100.4 now for the last five days. The patient also felt joint soreness most of the time.  The soreness and fever subsides during the day but returns nightly. The patient wake up with sweet-drenched clothing each morning as well. The patient wanted to know was this normal after the shot and when could he/she expect these symptoms to go away.
Rash covering upper arm 24 hours after I initial vaccine, issues with severe indigestion and bloating (countered with probiotics within a few days), then candida infection on genitals, under breasts, and armpits (treated with over-the-counter miconazole nitrate suppositories and topical cream,  and prescribed fluconazole.) No past history of any of these symptoms nor conditions.
Pt recvd 3 doses of Engerix-B 8MAY91; 4JN91 & 11NOV91 & 11NOV91 immed p/3rd inject pt exp burning while inject was being given which cont for a few hrs;
Left upper arm pain with erythema and swelling from deltoid to biceps with tenderness to palpation. Redness occured within 10 minutes of receiving injection, swelling noticed the next day on 1/30/19. Abdominal pain/nausea/vomiting within 30 minutes of injection, resolved by next day.
low grade fever; This case was reported by a physician via sales rep and described the occurrence of fever in a 16-year-old male patient who received Men B NVS (Bexsero) for prophylaxis.   Concomitant products included Men B NVS (Bexsero).   On an unknown date, the patient received Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. The patient Bexsero completed series. The patient experienced low grade fever. This case has been linked with case US2020AMR171971 reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR171971:same reporter
Information has been received from a registered nurse concerning an adult female patient who, on an unspecified date, was vaccinated with an unknown number of rubella virus vaccine II and failed to serooconvert. It was reported that she had "the same problem with her rubella vaccinations", that her sister had experienced (WAES01051551). The nurse stated that she did not have any further vaccination information due to the fact that the vaccinations were not administered there.  No further information is available.
Headache chills, body aches (unspecified),mild chest pain, swelling at injection site Narrative:
Woke up in the middle of the night with a very terrible chest pain with a tight pressure; Woke up in the middle of the night with a very terrible chest pain with a tight pressure; Hurt like when I swallow eating they hurt; This is a spontaneous report from a contactable consumer or other non healthcare professional. A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 27Apr2021 (Batch/Lot Number: ER8729) as DOSE 1, SINGLE for covid-19 immunisation..The patient medical history and concomitant medications was not reported. The patient experienced woke up in the middle of the night with a very terrible chest pain with a tight pressure causing chest pain on an unspecified date with outcome of unknown, woke up in the middle of the night with a very terrible chest pain with a tight pressure with  chest discomfort on an unspecified date with outcome of unknown, hurt like when she swallow eating they hurt causing odynophagia on an unspecified date with outcome of unknown.  No Follow-up attempts completed. No further information is expected.
Pt exp hurting all over, bones aching, stomach cramps, chills, temp 100, dizziness, nausea, extreme fatigue, arm red & swollen @ inject site;
I began experiencing hive to cold weather and cold water. Anything below about 60 my body develops hive on exposed skin and covered such as face, neck, thighs, feet, hands. Also known as Urticaria.
About five minutes after shot, pt was talking and moving around with her walker. Pt said she felt nauseated and that her pulse and heart were racing. It was only after shot that even though I asked her if previous Rxn to shot that she said that she had problems with it. Pt allergic to EPI, so we took her BP/Pulse, it was high. She rested for about 20 mins and took some ASA, and she was fine when she left.
This study case was received from the investigator on 30 November 2011. A 35 year-old male subject with no significant medical history was found to have to have an unspecified disease of the pericardium 12 days after he had received on 17 August 2011 ACAM2000 (lot number, route and site of administration not reported). The subject also received an injection of TYPHIM Vi (lot number, route and site of administration not reported) on 04 August 2011 and anthrax 1 (manufacturer, lot number, route and site of administration not reported) on 31 July 2011. Relevant laboratory data included: an abnormal Troponin I with the highest recorded value not reported on 29 August 2011. The subject's ECG and echocardiogram on 29 August 2011 were normal. A lumbar puncture and MRI of the brain, spinal cord and heart were not performed. Treatments were not reported. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: none.
Information has been received from a physician's assistant concerning a 20 year old female with no drug reactions/allergies and no pertinent medical history who on 11-JAN-2008 was vaccinated with GARDASIL (lot#653938/0954F) 0.5 mL IM. Concomitant therapy included hormonal contraceptives (unspecified). On approximately 12-JAN-2008 or 13-JAN-2008 the patient experienced swelling of neck with a rash and bumps on the neck, no difficulty breathing. Unspecified medical attention was sought in the office. On an unspecified date the symptoms resolved in a few days. No additional information at this time. Additional information has been requested.
The next morning following the first dose of my covid 19 vaccine I noticed a ringing in my right ear. This has continued  into my left ear as well. However my ear is the worst by far. That was 6 months ago, and my ears continue to ring. I have seen an ENT and I do not have hearing loss but they stated they are seeing more and more people coming in for this side effect.
Tonic seizure activity of approximately 45 secs duration followed almost immediately by a second episode that included decorticate rigidity. Administered 0.3mg epinephrine by EpiPen. Transported by EMS in stable condition to local emergency room.
No Adverse event; Patient may have gotten the monovalent Moderna booster after the Bivalent vaccine was authorized/nurse swore that it was not the Moderna Bivalent booster at the time of administration; This spontaneous case was reported by a patient family member or friend and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient may have gotten the monovalent Moderna booster after the Bivalent vaccine was authorized/nurse swore that it was not the Moderna Bivalent booster at the time of administration) and NO ADVERSE EVENT (No Adverse event) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Patient may have gotten the monovalent Moderna booster after the Bivalent vaccine was authorized/nurse swore that it was not the Moderna Bivalent booster at the time of administration). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient may have gotten the monovalent Moderna booster after the Bivalent vaccine was authorized/nurse swore that it was not the Moderna Bivalent booster at the time of administration) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.            No concomitant drug was reported.  Reporter stated that there was some confusion when the vaccine was given on 02-Sep-2022. Reporter had a heated discussion with the vaccination facility but they could not really tell them specifically.  Reporter stated the vaccine facility told them after 01-Sep-2022 that was all they were administering would be the Moderna Bivalent booster. The nurse who administered the vaccine at the time did not put that on the card, nurse swore that was not the Moderna Bivalent booster at the time of administration.  Reporter was speaking on behalf of his mother who might or might not received the Moderna bivalent booster dose.  Patient was told not to wait to get the Bivalent and to get whatever vaccine the facility had they had. Patient might have gotten the monovalent Moderna booster after the Bivalent vaccine was authorized. Reporter further stated that if they did not find out which vaccine their mother received they might need to give them another Bivalent booster dose (potentially receiving two Bivalent booster doses).  No treatment drug was reported.